Comp En De Mn Cemig ADS (NYSE:CIG - Get Free Report)'s stock price crossed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $1.84 and traded as high as $2.02. Comp En De Mn Cemig ADS shares last traded at $2.01, with a volume of 1,838,299 shares trading hands.
Analyst Upgrades and Downgrades
Separately, Bank of America cut Comp En De Mn Cemig ADS from a "neutral" rating to an "underperform" rating in a research note on Tuesday, April 1st.
Get Our Latest Report on CIG
Comp En De Mn Cemig ADS Stock Up 1.5%
The stock has a 50 day moving average price of $1.88 and a 200-day moving average price of $1.84. The stock has a market capitalization of $5.75 billion, a P/E ratio of 4.33 and a beta of 1.06. The company has a debt-to-equity ratio of 0.46, a current ratio of 1.06 and a quick ratio of 1.06.
Comp En De Mn Cemig ADS Company Profile
(
Get Free Report)
Companhia Energética de Minas Gerais, through its subsidiaries, engages in the generation, transmission, distribution, and sale of electricity in Brazil. The company generates electricity through renewable energy sources, such as water, wind, sun, and biomass; or non-renewable sources, including fossil and nuclear fuels.
Featured Articles
Before you consider Comp En De Mn Cemig ADS, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Comp En De Mn Cemig ADS wasn't on the list.
While Comp En De Mn Cemig ADS currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
